Bayer sells animal health division for $7.6 billion, denies deal prompted by glyphosate-cancer lawsuits

s reutersmedia net
Credit: Reuters

Agriculture and pharmaceutical giant Bayer [August 20] agreed [to] a $7.6 billion deal to sell its animal health business to U.S.-based animal health company Elanco …. The deal with Elanco means Bayer will now no longer make products that prevent and treat diseases in farm animals and pets.

Bayer finds itself in a tough political situation after its $63 billion acquisition of glyphosate-maker Monsanto last year. Having taken on the liability for the controversial weedkiller, Bayer has been facing a wave of claims from plaintiffs saying glyphosate caused their cancer …. Bayer …. denied any link between the glyphosate lawsuits and the animal health sell-off.

Related article:  'Children killer' glyphosate found in Cheerios? Experts dismantle Environmental Working Group's herbicide food residue study

Read full, original article: Bayer sells animal health business (Behind paywall)

ADVERTISEMENT
Outbreak Daily Digest
Biotech Facts & Fallacies
Genetics Unzipped
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend